Behavioral treatment of hypertensive heart disease in african americans: Rationale and design of a randomized controlled trial

Behavioral Medicine

Volumn 27, Issue 2, 2001, Pages 83-95

  Schneider, Robert H ^a   Castillo Richmond, Amparo ^a   Alexander, Charles N ^b   Myers, Hector ^d,e   Kaushik, Vidya ^c   Aranguri, Cesar ^c   Norris, Keith ^b   Haney, Chinelo ^d   Rainforth, Maxwell ^a   Calderon, Raul ^a   Nidich, Sanford ^a  

^a MAHARISHI UNIVERSITY OF MANAGEMENT   (United States)

^b Department of Psychology ^*  (United States)

^c DREW UNIVERSITY   (United States)

^d Research Program for Ethnicity and Health   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Hypertension; Left ventricular hypertrophy; Stress reduction; Transcendental meditation

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; ATHEROSCLEROSIS; B SCAN; BEHAVIOR THERAPY; BLOOD PRESSURE MONITORING; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LIFESTYLE; M MODE ECHOCARDIOGRAPHY; NEGRO; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL PROBLEM; STRESS;

ADULT; AFRICAN AMERICANS; AGED; ARTERIOSCLEROSIS; BEHAVIOR THERAPY; CAROTID ARTERY DISEASES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0035205427     PISSN: 08964289     EISSN: None     Source Type: Journal    
DOI: 10.1080/08964280109595775     Document Type: Article

References (143)

1. Preventive medicine for our ailing health care system
2. Mortality rates and risk factors for coronary disease in black as compared to white men and women
3. Coronary heart disease among blacks and whites in the NHANES-I Epidemiologic Follow-Up Study: Incidence of new events and risk factor prediction
4. Prevalence of hypertension in the U.S. Population: Results from the Third National Nutrition and Examination Survey, 1988-1991
5. Heart disease, stroke, and hypertension in blacks
6. Automatic reactivity and hypertension in blacks: A review and proposed model
7. Coronary heart disease risk factors in men and women aged 60 years and older: Findings from the Systolic Hypertension in the Elderly Program
8. Low-risk factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle aged men and women
9. Toward understanding the association of socioeconomic status and health: A new challenge for biopsychosocial approach
10. The effect of known risk factors on the excess mortality of black adults in the United States
11. Health promotion and African-Americans: From personal empowerment to community action
12. Acute psychophysiologic reactivity and risk of cardiovascular disease: A review and methodologic critique
13. Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: A population-based study
14. Socioeconomic status, John Henryism, and hypertension in blacks and whites
15. Anger and anxiety in borderline hypertension
16. Associations of blood pressure with self-report measures of anger and hostility among black and white men and women
17. Negative affect as a prospective risk factor for hypertension
18. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study
19. The heart in hypertension
20. Hypertensive left ventricular hypertrophy: Pathogenesis, prognostic importance and treatment
21. Echocardiographic Left Ventricular Hypertrophy in Blacks
22. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension
23. Hypertension and the heart
24. Hemodynamic function at rest, during stress, and in the field: Predictors of cardiac structure and function 2 years later in youth
25. Rapid filling in left ventricular hypertrophy: II. Pathological hypertrophy
26. Importance of obesity, race and age to the structural and functional effects of hypertension
27. Echocardiographic correlates of left ventricular structure among 844 mild hypertensive men and women in the treatment of mild hypertension study (TOMHS)
28. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom
29. Time-voltage area of the QRS for the identification of left ventricular hypertrophy
30. Utility of new electrocardiographic models for left ventricular mass in older adults: The Cardiovascular Health Study Collaborative Research Group
31. Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy
32. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: Results of a correlated data base approach
33. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: The Losartan Intervention for Endpoint Reduction (LIFE) in Hypertension Study
34. Black-White differences in electrocardiographic left ventricular mass and its association with blood pressure (The ARIC Study)
35. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study (Coronary Artery Risk Development in Young Adults)
36. Nonsustained ventricular tachycardia as a predictor of cardiovascular events in black men with hypertensive left ventricular hypertrophy
37. The epidemiology of cardiovascular disease: An American overview
38. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension
39. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults
40. Effect of African American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function
41. Racial differences in myocardial ischemia and coronary flow reserve in hypertension
42. Survival rates with coronary artery disease for black women compared with black men
43. Continued adverse trends in coronary heart disease mortality among blacks, 1980-91
44. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (The Framingham Study)
45. Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension
46. Left ventricular diastolic filling alterations in normotensive young adults with a family history of systemic hypertension
47. Correlates of diastolic filling abnormalities in hypertension: A Doppler echocardiographic study
48. Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients
49. Reversal of diastolic dysfunction in borderline hypertension by long-term medical treatment-Longitudinal evaluation by pulsed Doppler echocardiography
50. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study
51. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischemic Heart Disease Risk Factor Study
52. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity
53. Arterial imaging and atherosclerosis reversal: George Lyman Duff Memorial Lecture
54. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group
55. Cardiac and arterial hypertrophy and atherosclerosis in hypertension
56. Parallel cardiac and vascular adaptation in hypertension
57. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects
58. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults
59. Effects of acute mental stress on serum lipids: Mediating effects of plasma volume
60. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
61. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: Findings from the Kuopio Ischemic Heart Disease Study
62. Psychological stress and the progression of carotid artery disease
63. Psychological and physiological predictors of lipids in black males
64. Work organization and atherosclerosis findings from the ARIC study (Atherosclerosis Risk in Communities)
65. Effect of Transcendental Meditation on serum cholesterol and blood pressure
66. Lower lipid peroxide levels in practitioners of the Transcendental Meditation Program
67. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans
68. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
69. Shortcomings of current antihypertensive therapy
70. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)-A randomized controlled trial
71. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP)
72. Echocardiography in hypertension: A review. II. Echocardiography studies of the effects of antihypertensive agents on left ventricular wall mass and function
73. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies
74. Treatment of Mild Hypertension Study-Final results
75. Reversal of left ventricular hypertrophy in essential hypertension-A meta-analysis of randomized double-blind studies
76. Hypertension detection, treatment and control, a call to action for cardiovascular specialists
77. Transcendental Meditation, self-actualization and psychological ealth: A conceptual overview and statistical meta-analysis
78. A randomized controlled trial of stress reduction for hypertension in older African Americans
79. A trial of stress reduction for hypertension in older African Americans (Part II): Sex and risk factor subgroup analysis
80. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
81. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension
82. The Treatment of Mild Hypertension Study - TOMHS A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drugs monotherapies
83. A wakeful hypo-metabolic physiologic state
84. The effects of Transcendental Meditation compared to other methods of relaxation and meditation in reducing risk factors, morbidity, and mortality
85. Physiological differences between Transcendental Meditation and rest
86. Beta-adrenergic receptor sensitivity in subjects practicing Transcendental Meditation
87. Meditation as an intervention in stress reactivity
88. Adrenocortical activity during meditation
89. Short-term longitudinal effects of the Transcendental Meditation technique on EEG power and coherence
90. Redistribution of blood flow in acute hypo-metabolic behavior
91. Differential effects of relaxation techniques on trait anxiety: A meta-analysis
92. In search of an optimal behavioral treatment for hypertension: A review and focus on Transcendental Meditation
93. Transcendental Meditation, mindfulness, and longevity: An experimental study with the elderly
94. Influence of arterial blood pressure and non-hemodynamic factors on left ventricular hypertrophy in moderate essential hypertension
95. Stress reduction and preventing hypertension: Preliminary support for a psychoneuroendocrine mechanism
96. The Transcendental Meditation Program and rehabilitation at Folsom State Prison: A cross-validation study
97. Transcendental Meditation and the treatment of post-Vietnam adjustment
98. Ego development, personality and behavioral change in inmates practicing the Transcendental Meditation technique or participating in other programs: A cross-sectional and longitudinal study
99. Effects of the Transcendental Meditation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults
100. Medical care utilization and the Transcendental Meditation program
101. The impact of the Transcendental Meditation program on government payments to physicians in Quebec
102. A randomized controlled trial of stress reduction on cardiovascular and all-cause mortality in the elderly: Results of 8 and 15 year follow-ups
103. The effects of non-pharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase 1
104. Echocardiography in hypertension: A review. I. Left ventricular mass, standardization, and left ventricular function
105. Echocardiographic determination of left ventricular mass in man-Anatomic validation of the method
106. A formula to estimate the approximate surface area if height and weight be known
107. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
108. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study
109. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II. Clinical studies
110. Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (The Framingham Heart Study)
111. Evaluation of left ventricular diastolic function
112. The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection
113. Perceived health and mortality: A nine-year follow-up of the human population laboratory cohort
114. Subjective state of health and survival in elderly adults
115. Physician utilization and expenditure in Medicaid population
116. Assessment of quality of life in clinical trials of cardiovascular therapies
117. Comparison of the Medical Outcomes Study Short-Form 36-Item Health Survey in black patients and white patients with acute chest pain
118. The experience and expression of anger: Construction and validation of an anger expression scale
119. A global measure of perceived stress
120. Evaluating the efficacy of physical activity for influencing quality of life outcomes in older adults
121. The Hopkins Sympton Check List (HSCL): A self-report sympton inventory
122. A five-item measure of socially desirable response set
123. Development and validation of dietary assessment methods for culturally diverse populations
124. Does cardiovascular reactivity have pathogenic significance in hypertensive patients?
125. Ambulatory blood pressure monitoring and laboratory reactivity in Type A behavior and components
126. A computerized diary (CAD) for ambulatory blood pressure monitoring